Immunogenicity and safety of a new hexavalent rotavirus vaccine in Chinese infants: A randomized, double-blind, placebo-controlled phase 2 clinical trial

• Main Authors: Zhi-Wei Wu (Author), Fei Jin (Author), Qing-Liang Li (Author), Jia-Mei Gao (Author), Hai-Song Zhou (Author), Kai Duan (Author), Zhao Gao (Author), Yan Liu (Author), Zhi-Yong Hao (Author), Wei Chen (Author), Yue-Yue Liu (Author), Ge-Lin Xu (Author), Biao Yang (Author), Ben Dong (Author), Jiu-Wei Zhang (Author), Yu-Liang Zhao (Author), Xiao-Ming Yang (Author)
• Format: Book
• Published: Taylor & Francis Group, 2023-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Rotavirus remains a major cause of diarrhea among 5-y-old children, and vaccination is currently the most effective and economical measure. We conducted a randomized, double-blind, placebo-controlled phase II clinical trial designed to determine the dosage, immunogenicity, and safety profile of a no...